To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Beckman Announces Sale of Minority Interest in Agencourt Personal Genomics
Beckman Coulter, Inc. has announced it has entered into an agreement to sell the company's minority interest in Agencourt Personal Genomics (APG).
This follows from an agreement between APG and Applied Biosystems Group, an Applera Corporation business whereby Applied Biosystems will acquire APG subject to regulatory and other customary closing conditions.
Beckman Coulter acquired shares of APG in conjunction with its acquisition of Agencourt Bioscience in May 2005.
Beckman Coulter expects to receive about $50 million in cash from the transaction which is anticipated to close in the third quarter of 2006.
Add Technology Networks as a preferred Google source to see more of our trusted coverage.
